TNF-α is involved in the mechanisms that initiate inflammatory bowel diseases (IBDs). Anti-TNF-α drugs, such as infliximab (IFX), cause non-responsiveness and side effects, indicating the need to investigate alternative therapies for these diseases. The anti-inflammatory protein, annexin A1 (AnxA1), has been associated with the protection of the gastrointestinal mucosa. To further address the role of endogenous AnxA1 on the TNF-α blockade efficacy in a murine model, we assessed colitis induced by Dextran Sulfate Sodium (DSS) in wild-type (WT) and AnxA1−/− Balb/c mice treated with IFX. We consistently observed endogenous AnxA1 prevented clinical and physiological manifestations of experimental colitis treated with IFX, additionally the manif...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
We evaluated whether the lack of TNF-α signaling increases mucosal levels of annexin A1 (AnxA1); the...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
<div><p>Annexin A1 (ANXA1) inhibits NF-κB, a key regulator of inflammation, the common pathophysiolo...
PubMed ID: 22723974This is an open-access article distributed under the terms of the Creative Common...
TNFα is an important cytokine in inflammatory bowel disease. V565 is a novel anti-TNFα domain antibo...
Annexin A1 (ANXA1) inhibits NF-kB, a key regulator of inflammation, the common pathophysiological me...
23noExtracellular nicotinamide phosphoribosyltransferase (eNAMPT) is increased in inflammatory bowel...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
We evaluated whether the lack of TNF-α signaling increases mucosal levels of annexin A1 (AnxA1); the...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Development of inflammatory bowel disease (IBD) involves the interplay of environmental and genetic ...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
BackgroundDevelopment of inflammatory bowel disease (IBD) involves the interplay of environmental an...
Background: Development of inflammatory bowel disease (IBD) involves the interplay of environmental ...
<div><p>Annexin A1 (ANXA1) inhibits NF-κB, a key regulator of inflammation, the common pathophysiolo...
PubMed ID: 22723974This is an open-access article distributed under the terms of the Creative Common...
TNFα is an important cytokine in inflammatory bowel disease. V565 is a novel anti-TNFα domain antibo...
Annexin A1 (ANXA1) inhibits NF-kB, a key regulator of inflammation, the common pathophysiological me...
23noExtracellular nicotinamide phosphoribosyltransferase (eNAMPT) is increased in inflammatory bowel...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...
Background The proinflammatory cytokines interleukin 1 beta (IL-1 beta) and IL-18 are central player...